Celldex Therapeutics, Inc vs. QuidelOrtho Corporation Common Stock
CLDX
Celldex Therapeutics, Inc
$38.71 +0.52%
VS QDELQuidelOrtho Corporation Common Stock
$11.78 -3.05%
Celldex Therapeutics, Inc and QuidelOrtho Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CLDX | QDEL | |
|---|---|---|
| Market Cap | $3.02 billion | $833.19 million |
| Revenue (TTM) | — | $2.67 billion |
| Net Income (TTM) | — | $-1,048,400,000 |
CLDX leads on 1 of 1 size & scale factors.
Valuation
| CLDX | QDEL | |
|---|---|---|
| Price / Book | — | 0.47 |
| Price / Sales | — | 0.31 |
CLDX and QDEL split the valuation factors evenly.
Profitability
| CLDX | QDEL | |
|---|---|---|
| Net Margin | — | -39.20% |
| Return on Equity | — | -59.07% |
CLDX and QDEL split the profitability factors evenly.
Risk & Sentiment
| CLDX | QDEL | |
|---|---|---|
| Short Interest | 9.28% | 5.40% |
QDEL leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, QDEL overview, QDEL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.